VCP Is Essential for Mitochondrial Quality Control by PINK1/Parkin and this Function Is Impaired by VCP Mutations

详细信息    查看全文

• 作者：Nam Chul Kim¹ ; ⁵ ; Emilie Tresse¹ ; ⁵ ; Regina-Maria Kolaitis¹ ; Amandine Molliex¹ ; Ruth E. Thomas⁴ ; Nael H. Alami¹ ; Bo Wang² ; Aashish Joshi² ; Rebecca B. Smith¹ ; Gillian P. Ritson¹ ; Brett J. Winborn¹ ; Jennifer Moore¹ ; Joo-Yong Lee³ ; Tso-Pang Yao³ ; Leo Pallanck⁴ ; Mondira Kundu² ; J. Paul Taylor¹ ; ^{jpaul.taylor@stjude.org}
• 刊名：Neuron
• 出版年：2013
• 出版时间：10 April, 2013
• 年：2013
• 卷：78
• 期：1
• 页码：65-80
• 全文大小：2649 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencescoding=""UTF-8""?>

class=""h3"">Summary

Mutations in VCP cause multisystem degeneration?impacting the nervous system, muscle, and/or bone. Patients may present with ALS, Parkinsonism, frontotemporal dementia, myopathy, Paget¡¯s disease, or a combination of these. The disease mechanism is unknown. We developed a Drosophila model of VCP mutation-dependent degeneration. The phenotype is reminiscent of PINK1 and parkin mutants, including a pronounced mitochondrial defect. Indeed, VCP interacts genetically with the PINK1/parkin pathway in?vivo. Paradoxically, VCP complements PINK1 deficiency but not parkin deficiency. The basis of this paradox is resolved by?mechanistic studies in?vitro showing that VCP recruitment to damaged mitochondria requires Parkin-mediated ubiquitination of mitochondrial targets. VCP recruitment coincides temporally with mitochondrial fission, and VCP is required for proteasome-dependent degradation of Mitofusins in?vitro and in?vivo. Further, VCP and its adaptor Npl4/Ufd1 are required for clearance of damaged mitochondria via the PINK1/Parkin pathway, and this is impaired by pathogenic mutations in VCP.